84% of patients with diabetes want to use non-invasive glucose monitoring
Finger prick testing is a painful and frustrating process, especially for children or the elderly people suffering from peripheral circulatory diseases.
IQ Biozoom enhances a management of personal health painlessly.
How it works?
Why IQ Biozoom?
Life quality improvement
Our groundbreaking technology enables the non-invasive, pain-free saliva-based glucose monitoring that replaces finger-prick testing for people with diabetes.
We are developing the salivary glucose biosensing technology to improve the quality of life of over 422 million people living with diabetes worldwide.
Technology of thin-film transistors
The IQ Biozoom technology is 10 times more sensitive than state-of-the-art blood glucose tests. Our salivary-based glucose biosensing technology was invented by the IQ Biozoom team in Poland. The core scientific innovation lies in the use of thin-film transistors embedded with the enzymes that to initiate an electrochemical reaction that transforms the biochemical reactions into an electrical signal proportional to the glucose concentration.
With our Biosensing Platform, we introduce life-changing medical innovations. IQ Biozoom will develop and launch painless, real-time diagnostic tests which can be used by patients and medical professionals at point-of-care. Our first step is a technology for non-invasive glucose monitoring.
The IQ Biozoom technology will make the diagnostic procedure, analysis time and cost significantly simpler, shorten, and reduced.